Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination

被引:23
作者
Brooks, CD
Francom, SF
Peel, BG
Chene, BL
Klott, KA
机构
[1] Upjohn Research Clinics, Michigan State University College of Human Medicine, Department of Pediatrics and Human Development, Kalamazoo
来源
AMERICAN JOURNAL OF RHINOLOGY | 1996年 / 10卷 / 03期
关键词
D O I
10.2500/105065896781794941
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Sixty ragweed-sensitive volunteers participated in a 2-week study that compared symptom profiles during treatment with antihistamine (loratadine, LOR) alone, topical corticoid (beclomethasone, BEG) alone, or the two drugs combined. For 5 days commencing shortly after the beginning of the ragweed bloom, patients took no treatment while we collected baseline data. They were then randomized to one of the three treatments, receiving that treatment for the balance of the 2-week study term. Twice each day they recorded the severity of congestion, eye symptoms, running and blowing, itching and sneezing. At the end of the study they provided an estimate of overall symptom relief which favored combined treatment (vs LOR P = 0.001, vs BEC P = 0.042). To gain an estimate of disease severity and treatment effectiveness over time, and to smooth out day-to-day variation, we divided symptom diary reports into three segments (days 2-4, 5-7, and 8-10) for analysis. Combined treatment controlled symptoms better than antihistamine alone in nearly all study segments. Corticoid alone or combined with antihistamine provided similar control of congestion, running and blowing, and eye complaints. Combination therapy controlled itching and sneezing better, especially through the study segments 1 and 2. Patient preference for combined treatment seems to relate to control of itching and sneezing and rapid onset of effect.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 10 条
  • [1] BACKHOUSE CI, 1986, J INT MED RES, V14, P35
  • [2] PROFILE OF RAGWEED HAY-FEVER SYMPTOM CONTROL WITH TERFENADINE STARTED BEFORE OR AFTER SYMPTOMS ARE ESTABLISHED
    BROOKS, CD
    KARL, KJ
    FRANCOM, SF
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (01) : 21 - 26
  • [3] ORAL METHYLPREDNISOLONE ACETATE (MEDROL TABLETS) FOR SEASONAL RHINITIS - EXAMINATION OF DOSE AND SYMPTOM RESPONSE
    BROOKS, CD
    KARL, KJ
    FRANCOM, SF
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (09) : 816 - 822
  • [4] BROOKS CD, 1995, J ALLERGY CLIN IMMUN, V95, P192
  • [5] DEXAMETHASONE DOES NOT INHIBIT THE RELEASE OF MEDIATORS FROM HUMAN MAST-CELLS RESIDING IN AIRWAY, INTESTINE, OR SKIN
    COHAN, VL
    UNDEM, BJ
    FOX, CC
    ADKINSON, NF
    LICHTENSTEIN, LM
    SCHLEIMER, RP
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (04): : 951 - 954
  • [6] D'SOUZA M F, 1990, Clinical and Experimental Allergy, V20, P100
  • [7] COMPARISON OF BECLOMETHASONE DIPROPIONATE AQUEOUS NASAL SPRAY, ASTEMIZOLE, AND THE COMBINATION IN THE PROPHYLACTIC TREATMENT OF RAGWEED POLLEN INDUCED RHINOCONJUNCTIVITIS
    JUNIPER, EF
    KLINE, PA
    HARGREAVE, FE
    DOLOVICH, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (03) : 627 - 633
  • [8] EFFECT OF BECLOMETHASONE DIPROPIONATE ON NASAL METACHROMATIC CELL SUBPOPULATIONS
    OTSUKA, H
    DENBURG, JA
    BEFUS, AD
    HITCH, D
    LAPP, P
    RAJAN, RS
    BIENENSTOCK, J
    DOLOVICH, J
    [J]. CLINICAL ALLERGY, 1986, 16 (06): : 589 - 595
  • [9] NASAL MUCOSAL MAST-CELLS AND HISTAMINE IN HAY-FEVER - EFFECT OF TOPICAL GLUCOCORTICOID TREATMENT
    PIPKORN, U
    ENERBACK, L
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 84 (02): : 123 - 128
  • [10] SIMPSON RJ, 1994, ANN ALLERGY, V73, P497